Literature DB >> 12738781

Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate.

Hiroyuki Nakajima1, Fumiko Toyoshima-Morimoto, Eri Taniguchi, Eisuke Nishida.   

Abstract

Plk1 (Polo-like kinase 1), an evolutionarily conserved serine/threonine kinase, is crucially involved in multiple events during the M phase. Here we have identified a consensus phosphorylation sequence for Plk1, by testing the ability of systematically mutated peptides derived from human Cdc25C to serve as a substrate for Plk1. The obtained results show that a hydrophobic amino acid at position +1 carboxyl-terminal of phosphorylated Ser/Thr and an acidic amino acid at position -2 are important for optimal phosphorylation by Plk1. We have then found that Myt1, an inhibitory kinase for MPF, has a number of putative phosphorylation sites for Plk1 in its COOH-terminal portion. While wild-type Myt1 (Myt1-WT) served as a good substrate for Plk1 in vitro, a mutant Myt1 (Myt1-4A), in which the four putative phosphorylation sites are replaced by alanines, did not. In nocodazole-treated cells, Myt1-WT, but not Myt1-4A, displayed its mobility shift in gel electrophoresis, due to phosphorylation. These results suggest that Plk1 phosphorylates Myt1 during M phase. Thus, this study identifies a novel substrate for Plk1 by determining a consensus phosphorylation sequence by Plk1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738781     DOI: 10.1074/jbc.C300126200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  148 in total

Review 1.  Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cells.

Authors:  Petr Solc; Richard M Schultz; Jan Motlik
Journal:  Mol Hum Reprod       Date:  2010-05-07       Impact factor: 4.025

2.  Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.

Authors:  David V Hansen; Alexander V Loktev; Kenneth H Ban; Peter K Jackson
Journal:  Mol Biol Cell       Date:  2004-10-06       Impact factor: 4.138

3.  Plk1 docking to GRASP65 phosphorylated by Cdk1 suggests a mechanism for Golgi checkpoint signalling.

Authors:  Christian Preisinger; Roman Körner; Mathias Wind; Wolf D Lehmann; Robert Kopajtich; Francis A Barr
Journal:  EMBO J       Date:  2005-01-27       Impact factor: 11.598

4.  Female infertility in PDE3A(-/-) mice: polo-like kinase 1 (Plk1) may be a target of protein kinase A (PKA) and involved in meiotic arrest of oocytes from PDE3A(-/-) mice.

Authors:  Weixing Shen; Faiyaz Ahmad; Steven Hockman; John Ma; Hitoshi Omi; Nalini Raghavachari; Vincent Manganiello
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

5.  A coupled chemical-genetic and bioinformatic approach to Polo-like kinase pathway exploration.

Authors:  Jennifer L Snead; Matthew Sullivan; Drew M Lowery; Michael S Cohen; Chao Zhang; David H Randle; Jack Taunton; Michael B Yaffe; David O Morgan; Kevan M Shokat
Journal:  Chem Biol       Date:  2007-11

6.  A quantitative atlas of mitotic phosphorylation.

Authors:  Noah Dephoure; Chunshui Zhou; Judit Villén; Sean A Beausoleil; Corey E Bakalarski; Stephen J Elledge; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

Review 7.  Mitotic crisis: the unmasking of a novel role for RPA.

Authors:  Rachel William Anantha; James A Borowiec
Journal:  Cell Cycle       Date:  2009-02-21       Impact factor: 4.534

8.  Crystallization and preliminary X-ray diffraction studies on the human Plk1 Polo-box domain in complex with an unphosphorylated and a phosphorylated target peptide from Cdc25C.

Authors:  Begoña García-Alvarez; Sonia Ibañez; Guillermo Montoya
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-03-25

9.  The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.

Authors:  Kin-Yip Cheng; Edward D Lowe; John Sinclair; Erich A Nigg; Louise N Johnson
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

10.  Multiplexed random peptide library and phospho-specific antibodies facilitate human polo-like kinase 1 inhibitor screen.

Authors:  Kenji Tanaka; Mitsunori Koresawa; Masato Iida; Kazuhiro Fukasawa; Erica Stec; Jason Cassaday; Peter Chase; Keith Rickert; Peter Hodder; Toshimitsu Takagi; Hideya Komatani
Journal:  Assay Drug Dev Technol       Date:  2010-02       Impact factor: 1.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.